Financial Advocates Investment Management’s Gossamer Bio GOSS Stock Holding History

Financial Advocates Investment Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-78,616	Closed	-$86.5K	–	685
2025 Q1	$86.5K	Hold	78,616	–	–	0.01%	703
2024 Q4	$71.1K	Sell	78,616 -14,934	-16%	-$12.8K	﹤0.01%	733
2024 Q3	$92.3K	Sell	93,550 -13,300	-12%	-$12.8K	0.01%	742
2024 Q2	$96.3K	Buy	106,850 +39,000	+57%	+$29.2K	0.01%	709
2024 Q1	$80.1K	Sell	67,850 -30,500	-31%	-$33.6K	﹤0.01%	743
2023 Q4	$89.7K	Buy	98,350 +25,500	+35%	+$18.8K	0.01%	705
2023 Q3	$60.7K	Buy	+72,850	New	+$84K	﹤0.01%	688

Other funds holding GOSS

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Financial Advocates Investment Management's GOSS Position: Q2 2025 in Review

Financial Advocates Investment Management sold out of Gossamer Bio (GOSS) in Q2 2025, closing a stake of 78,616 shares — an estimated $86.5K sold.

Financial Advocates Investment Management first reported a position in GOSS in Q3 2023 and held it in 7 quarters. The position peaked at $96.3K in Q2 2024. 123 funds tracked by Wall St. Rank hold GOSS as of Q2 2025.

Financial Advocates Investment Management reported no remaining Gossamer Bio position as of Q2 2025 after selling out during the quarter.
Financial Advocates Investment Management sold 78,616 Gossamer Bio shares in Q2 2025, an estimated $86.5K.
Financial Advocates Investment Management first reported a position in Gossamer Bio in Q3 2023 and held it in 7 quarters.
Financial Advocates Investment Management's Gossamer Bio position peaked at $96.3K in Q2 2024.
123 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2025.

Based on Financial Advocates Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.